Reuters reports:
A federal judge on Friday stayed federal regulators’ approval of the abortion pill mifepristone, partially granting a request by anti-abortion groups and dealing another setback to abortion rights in the United States. The ruling by U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas, allows the Biden administration one week to appeal the decision.
The Hill reports:
The FDA can appeal the decision to the conservative 5th Circuit Court of Appeals, and the judge has given the federal government seven days to seek relief. The case could eventually reach the Supreme Court.
Kacsmaryk sided with the antiabortion group that brought the lawsuit and said the agency’s approval process was improperly rushed, and resulted in an unsafe drug regimen getting on the market.
The drug was first approved in 2000, a process that took more than four years. It is indicated for use in abortions up to 10 weeks into a pregnancy. Mifepristone is also used by OB-GYNs to manage early miscarriages.
Before being nominated by Trump, Kacsmaryk worked for the anti-LGBTQ hate group, the First Liberty Institute. In January, he advanced a challenge to the right to access contraception.
BREAKING: A Texas judge appointed by Trump has ruled to suspend the FDA approval of abortion pills nationwide, though the ruling won’t take effect for a week, giving the Biden admin time to appeal.
Background on the case: https://t.co/gFnvOqg0sJ
— Alice Miranda Ollstein (@AliceOllstein) April 7, 2023
BREAKING: An anti-abortion judge in Texas just ruled in the lawsuit challenging FDA approval of mifepristone. Our experts are reviewing the decision and will have more soon. This case is a frontal attack on a drug used in more than half of all US abortions. #MedicationAbortion https://t.co/qpRB6BmqxM
— Guttmacher Institute (@Guttmacher) April 7, 2023